{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:40:11Z","timestamp":1793900411586,"version":"4.8.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Science and Engineering Research Council of Canada","doi-asserted-by":"crossref","award":["Discovery Grant CRD Grant"],"award-info":[{"award-number":["Discovery Grant CRD Grant"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A practical strategy to discover sepsis specific proteins may be to compare the plasma peptides and proteins from patients in the intensive care unit with and without sepsis. The aim was to discover proteins and\/or peptides that show greater observation frequency and\/or precursor intensity in sepsis. The endogenous tryptic peptides of ICU-Sepsis were compared to ICU Control, ovarian cancer, breast cancer, female normal, sepsis, heart attack, Alzheimer\u2019s and multiple sclerosis along with their institution-matched controls, female normals and normal samples collected directly onto ice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Endogenous tryptic peptides were extracted from individual sepsis and control EDTA plasma samples in a step gradient of acetonitrile for random and independent sampling by LC\u2013ESI\u2013MS\/MS with a set of robust and sensitive linear quadrupole ion traps. The MS\/MS spectra were fit to fully tryptic peptides within proteins using the X!TANDEM algorithm. The protein observation frequency was counted using\u00a0the SEQUEST algorithm after selecting the single best charge state and peptide sequence for each MS\/MS spectra. The protein observation frequency of ICU-sepsis versus ICU Control was subsequently tested by Chi square analysis. The average protein or peptide log\n                      <jats:sub>10<\/jats:sub>\n                      precursor intensity was compared across disease and control treatments by ANOVA in the R statistical system.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Peptides and\/or phosphopeptides of common plasma proteins such as ITIH3, SAA2, SAA1, and FN1 showed increased observation frequency by Chi square (\u03c7\n                      <jats:sup>2<\/jats:sup>\n                      \u2009&gt;\u20099, p\u2009&lt;\u20090.003) and\/or precursor intensity in sepsis. Cellular gene symbols with large Chi square values from tryptic peptides included POTEB, CTNNA1, U2SURP, KIF24, NLGN2, KSR1, GTF2H1, KIT, RPS6KL1, VAV2, HSPA7, SMC2, TCEB3B, ZNF300, SUPV3L1, ADAMTS20, LAMB4, MCCC1, SUPT6H, SCN9A, SBNO1, EPHA1, ABLIM2, cB5E3.2, EPHA10, GRIN2B, HIVEP2, CCL16, TKT, LRP2 and TMF1 amongst others showed increased observation frequency. Similarly, increased frequency of tryptic phosphopeptides were observed from POM121C, SCN8A, TMED8, NSUN7, SLX4, MADD, DNLZ, PDE3B, UTY, DEPDC7, MTX1, MYO1E, RXRB, SYDE1, FN1, PUS7L, FYCO1, USP26, ACAP2, AHI1, KSR2, LMAN1, ZNF280D and SLC8A2 amongst others. Increases in mean precursor intensity in peptides from common plasma proteins such as ITIH3, SAA2, SAA1, and FN1 as well as cellular proteins such as COL24A1, POTEB, KANK1, SDCBP2, DNAH11, ADAMTS7, MLLT1, TTC21A, TSHR, SLX4, MTCH1, and PUS7L among others were associated with sepsis. The processing of SAA1 included the cleavage of the terminal peptide D\/PNHFRPAGLPEKY from the most hydrophilic point of SAA1 on the COOH side of the cystatin C binding that was most apparent in ICU-Sepsis patients compared to all other diseases and controls. Additional cleavage of SAA1 on the NH2 terminus side of the cystatin binding site were observed in ICU-Sepsis. Thus there was disease associated variation in the processing of SAA1 in ICU-Sepsis versus ICU controls or other diseases and controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Specific proteins and peptides that vary between diseases might be discovered by the random and independent sampling of multiple disease and control plasma from different hospital and clinics by LC\u2013ESI\u2013MS\/MS for storage in a relational SQL Server database and analysis with the R statistical system that will be a powerful tool for clinical research. The processing of SAA1 may play an unappreciated role in the inflammatory response to Sepsis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12014-020-09288-5","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T03:24:46Z","timestamp":1593660286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The plasma peptides of sepsis"],"prefix":"10.1186","volume":"17","author":[{"given":"Thanusi","family":"Thavarajah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia C.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur S.","family":"Slutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pete","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Romaschin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7124-1448","authenticated-orcid":false,"given":"John G.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"issue":"4","key":"9288_CR1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1039\/C6MB00656F","volume":"13","author":"KR Ludwig","year":"2017","unstructured":"Ludwig KR, Hummon AB. Mass spectrometry for the discovery of biomarkers of sepsis. Mol BioSyst. 2017;13(4):648\u201364.","journal-title":"Mol BioSyst"},{"issue":"8844","key":"9288_CR2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-N","volume":"341","author":"M Assicot","year":"1993","unstructured":"Assicot M, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515\u20138.","journal-title":"Lancet"},{"issue":"4","key":"9288_CR3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jmii.2016.12.002","volume":"51","author":"S Garcia-Obregon","year":"2018","unstructured":"Garcia-Obregon S, et al. Identification of a panel of serum protein markers in early stage of sepsis and its validation in a cohort of patients. J Microbiol Immunol Infect. 2018;51(4):465\u201372.","journal-title":"J Microbiol Immunol Infect"},{"issue":"7","key":"9288_CR4","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1021\/pr070047k","volume":"6","author":"Y Ren","year":"2007","unstructured":"Ren Y, et al. The alterations of mouse plasma proteins during septic development. J Proteome Res. 2007;6(7):2812\u201321.","journal-title":"J Proteome Res"},{"issue":"1","key":"9288_CR5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/SHK.0000000000000173","volume":"42","author":"J Jiao","year":"2014","unstructured":"Jiao J, et al. Identification of potential biomarkers by serum proteomics analysis in rats with sepsis. Shock. 2014;42(1):75\u201381.","journal-title":"Shock"},{"issue":"10","key":"9288_CR6","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1074\/mcp.M114.039446","volume":"13","author":"F Cuello","year":"2014","unstructured":"Cuello F, et al. Redox state of pentraxin 3 as a novel biomarker for resolution of inflammation and survival in sepsis. Mol Cell Proteomics. 2014;13(10):2545\u201357.","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"9288_CR7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1074\/mcp.M500045-MCP200","volume":"4","author":"WJ Qian","year":"2005","unstructured":"Qian WJ, et al. Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O\/18O labeling and the accurate mass and time tag approach. Mol Cell Proteomics. 2005;4(5):700\u20139.","journal-title":"Mol Cell Proteomics"},{"issue":"11","key":"9288_CR8","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1021\/pr060327k","volume":"5","author":"Z Shen","year":"2006","unstructured":"Shen Z, et al. Sepsis plasma protein profiling with immunodepletion, three-dimensional liquid chromatography tandem mass spectrometry, and spectrum counting. J Proteome Res. 2006;5(11):3154\u201360.","journal-title":"J Proteome Res"},{"issue":"10","key":"9288_CR9","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/CCM.0000000000001134","volume":"43","author":"A DeCoux","year":"2015","unstructured":"DeCoux A, et al. Plasma glycoproteomics reveals sepsis outcomes linked to distinct proteins in common pathways. Crit Care Med. 2015;43(10):2049\u201358.","journal-title":"Crit Care Med"},{"issue":"2","key":"9288_CR10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1021\/pr400814s","volume":"13","author":"Z Cao","year":"2014","unstructured":"Cao Z, et al. Proteomics reveals age-related differences in the host immune response to sepsis. J Proteome Res. 2014;13(2):422\u201332.","journal-title":"J Proteome Res"},{"issue":"1","key":"9288_CR11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0974-2700.58666","volume":"3","author":"C Punyadeera","year":"2010","unstructured":"Punyadeera C, et al. A biomarker panel to discriminate between systemic inflammatory response syndrome and sepsis and sepsis severity. J Emerg Trauma Shock. 2010;3(1):26\u201335.","journal-title":"J Emerg Trauma Shock"},{"issue":"3","key":"9288_CR12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cyto.2011.12.002","volume":"57","author":"D Andaluz-Ojeda","year":"2012","unstructured":"Andaluz-Ojeda D, et al. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine. 2012;57(3):332\u20136.","journal-title":"Cytokine"},{"issue":"1","key":"9288_CR13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13613-016-0153-5","volume":"6","author":"Y Yang","year":"2016","unstructured":"Yang Y, et al. Combination of C-reactive protein, procalcitonin and sepsis-related organ failure score for the diagnosis of sepsis in critical patients. Ann Intensive Care. 2016;6(1):51.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"9288_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1164\/rccm.201201-0037OC","volume":"186","author":"S Gibot","year":"2012","unstructured":"Gibot S, et al. Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med. 2012;186(1):65\u201371.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"9288_CR15","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1007\/s11033-014-3177-7","volume":"41","author":"J Liu","year":"2014","unstructured":"Liu J, Li J, Deng X. Proteomic analysis of differential protein expression in platelets of septic patients. Mol Biol Rep. 2014;41(5):3179\u201385.","journal-title":"Mol Biol Rep"},{"issue":"4","key":"9288_CR16","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1097\/CCM.0000000000002102","volume":"45","author":"MN Alder","year":"2017","unstructured":"Alder MN, et al. Olfactomedin-4 is a candidate marker for a pathogenic neutrophil subset in septic shock. Crit Care Med. 2017;45(4):e426\u201332.","journal-title":"Crit Care Med"},{"issue":"6","key":"9288_CR17","first-page":"1230","volume":"112","author":"E Malmstrom","year":"2014","unstructured":"Malmstrom E, et al. Targeted mass spectrometry analysis of neutrophil-derived proteins released during sepsis progression. Thromb Haemost. 2014;112(6):1230\u201343.","journal-title":"Thromb Haemost"},{"issue":"1","key":"9288_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/CCM.0b013e31819285f0","volume":"37","author":"CM Martin","year":"2009","unstructured":"Martin CM, et al. A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry. Crit Care Med. 2009;37(1):81\u20138.","journal-title":"Crit Care Med"},{"issue":"6","key":"9288_CR19","doi-asserted-by":"crossref","first-page":"R268","DOI":"10.1186\/cc10546","volume":"15","author":"DK Heyland","year":"2011","unstructured":"Heyland DK, et al. Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool. Crit Care. 2011;15(6):R268.","journal-title":"Crit Care"},{"issue":"9","key":"9288_CR20","doi-asserted-by":"crossref","first-page":"e0222403","DOI":"10.1371\/journal.pone.0222403","volume":"14","author":"N Hayashi","year":"2019","unstructured":"Hayashi N, et al. Multiple biomarkers of sepsis identified by novel time-lapse proteomics of patient serum. PLoS ONE. 2019;14(9):e0222403.","journal-title":"PLoS ONE"},{"issue":"5","key":"9288_CR21","doi-asserted-by":"crossref","first-page":"e1800389","DOI":"10.1002\/pmic.201800389","volume":"19","author":"G Pimienta","year":"2019","unstructured":"Pimienta G, et al. Plasma proteome signature of sepsis: a functionally connected protein network. Proteomics. 2019;19(5):e1800389.","journal-title":"Proteomics"},{"issue":"18","key":"9288_CR22","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/pmic.201000100","volume":"10","author":"A Tiss","year":"2010","unstructured":"Tiss A, et al. A well-characterised peak identification list of MALDI MS profile peaks for human blood serum. Proteomics. 2010;10(18):3388\u201392.","journal-title":"Proteomics"},{"issue":"16","key":"9288_CR23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0142-9612(00)00054-5","volume":"21","author":"RD Oleschuk","year":"2000","unstructured":"Oleschuk RD, et al. Characterization of plasma proteins adsorbed onto biomaterials. By MALDI-TOFMS. Biomaterials. 2000;21(16):1701\u201310.","journal-title":"By MALDI-TOFMS. Biomaterials"},{"issue":"5","key":"9288_CR24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0090-4295(01)01659-4","volume":"59","author":"H Tammen","year":"2002","unstructured":"Tammen H, et al. Detection of low-molecular-mass plasma peptides in the cavernous and systemic blood of healthy men during penile flaccidity and rigidity\u2014an experimental approach using the novel differential peptide display technology. Urology. 2002;59(5):784\u20139.","journal-title":"Urology"},{"issue":"4","key":"9288_CR25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1586\/14737159.2.4.312","volume":"2","author":"AM Ardekani","year":"2002","unstructured":"Ardekani AM, Liotta LA, Petricoin EF 3rd. Clinical potential of proteomics in the diagnosis of ovarian cancer. Expert Rev Mol Diagn. 2002;2(4):312\u201320.","journal-title":"Expert Rev Mol Diagn"},{"issue":"9306","key":"9288_CR26","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(02)07746-2","volume":"359","author":"EF Petricoin","year":"2002","unstructured":"Petricoin EF, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359(9306):572\u20137.","journal-title":"Lancet"},{"issue":"1","key":"9288_CR27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI26022","volume":"116","author":"J Villanueva","year":"2006","unstructured":"Villanueva J, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest. 2006;116(1):271\u201384.","journal-title":"J Clin Invest"},{"issue":"10","key":"9288_CR28","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1074\/mcp.M600229-MCP200","volume":"5","author":"J Villanueva","year":"2006","unstructured":"Villanueva J, et al. Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age. Mol Cell Proteomics. 2006;5(10):1840\u201352.","journal-title":"Mol Cell Proteomics"},{"issue":"3","key":"9288_CR29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1074\/mcp.M700397-MCP200","volume":"7","author":"J Villanueva","year":"2008","unstructured":"Villanueva J, et al. A sequence-specific exopeptidase activity test (SSEAT) for \u201cfunctional\u201d biomarker discovery. Mol Cell Proteomics. 2008;7(3):509\u201318.","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"9288_CR30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1373\/clinchem.2009.133363","volume":"56","author":"JF Timms","year":"2010","unstructured":"Timms JF, et al. Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancer. Clin Chem. 2010;56(2):262\u201371.","journal-title":"Clin Chem"},{"key":"9288_CR31","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1021\/pr2000013","volume":"11","author":"P Bowden","year":"2012","unstructured":"Bowden P, et al. Quantitative statistical analysis of standard and human blood proteins from liquid chromatography, electrospray ionization, and tandem mass spectrometry. J Proteome Res. 2012;11:2032\u201347.","journal-title":"J Proteome Res"},{"key":"9288_CR32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/pr030003l","volume":"2","author":"J Marshall","year":"2003","unstructured":"Marshall J, et al. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J Proteome Res. 2003;2:361\u201372.","journal-title":"J Proteome Res"},{"issue":"3","key":"9288_CR33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/biostatistics\/kxp006","volume":"10","author":"JE Eckel-Passow","year":"2009","unstructured":"Eckel-Passow JE, et al. An insight into high-resolution mass-spectrometry data. Biostatistics. 2009;10(3):481\u2013500.","journal-title":"Biostatistics"},{"issue":"9","key":"9288_CR34","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/pmic.200300522","volume":"3","author":"KA Baggerly","year":"2003","unstructured":"Baggerly KA, et al. A comprehensive approach to the analysis of matrix-assisted laser desorption\/ionization-time of flight proteomics spectra from serum samples. Proteomics. 2003;3(9):1667\u201372.","journal-title":"Proteomics"},{"issue":"3","key":"9288_CR35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1021\/pr034039p","volume":"3","author":"J Marshall","year":"2004","unstructured":"Marshall J, et al. Human serum proteins preseparated by electrophoresis or chromatography followed by tandem mass spectrometry. J Proteome Res. 2004;3(3):364\u201382.","journal-title":"J Proteome Res"},{"key":"9288_CR36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jprot.2009.08.004","volume":"73","author":"P Bowden","year":"2009","unstructured":"Bowden P, Beavis R, Marshall J. Tandem mass spectrometry of human tryptic blood peptides calculated by a statistical algorithm and captured by a relational database with exploration by a general statistical analysis system. J Proteomics. 2009;73:103\u201311.","journal-title":"J Proteomics"},{"key":"9288_CR37","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jprot.2011.11.002","volume":"75","author":"AK Florentinus","year":"2012","unstructured":"Florentinus AK, et al. Identification and quantification of peptides and proteins secreted from prostate epithelial cells by unbiased liquid chromatography tandem mass spectrometry using goodness of fit and analysis of variance. J Proteomics. 2012;75:1303\u201317.","journal-title":"J Proteomics"},{"key":"9288_CR38","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jprot.2011.08.011","volume":"75","author":"AK Florentinus","year":"2011","unstructured":"Florentinus AK, et al. The Fc receptor-cytoskeleton complex from human neutrophils. J Proteomics. 2011;75:450\u201368.","journal-title":"J Proteomics"},{"key":"9288_CR39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12014-017-9176-7","volume":"14","author":"J Dufresne","year":"2017","unstructured":"Dufresne J, et al. Random and independent sampling of endogenous tryptic peptides from normal human EDTA plasma by liquid chromatography micro electrospray ionization and tandem mass spectrometry. Clin Proteomics. 2017;14:41.","journal-title":"Clin Proteomics"},{"key":"9288_CR40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12014-017-9170-0","volume":"14","author":"J Dufresne","year":"2017","unstructured":"Dufresne J, et al. Freeze-dried plasma proteins are stable at room temperature for at least 1 year. Clin Proteomics. 2017;14:35.","journal-title":"Clin Proteomics"},{"key":"9288_CR41","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1021\/pr8005217","volume":"8","author":"M Tucholska","year":"2009","unstructured":"Tucholska M, et al. Human serum proteins fractionated by preparative partition chromatography prior to LC\u2013ESI\u2013MS\/MS. J Proteome Res. 2009;8:1143\u201355.","journal-title":"J Proteome Res"},{"key":"9288_CR42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ab.2018.02.025","volume":"549","author":"J Dufresne","year":"2018","unstructured":"Dufresne J, et al. A method for the extraction of the endogenous tryptic peptides (peptidome) from human EDTA plasma. Anal Biochem. 2018;549:188\u201396.","journal-title":"Anal Biochem"},{"issue":"6","key":"9288_CR43","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jprot.2010.02.022","volume":"73","author":"M Tucholska","year":"2010","unstructured":"Tucholska M, et al. The endogenous peptides of normal human serum extracted from the acetonitrile-insoluble precipitate using modified aqueous buffer with analysis by LC-ESI-Paul ion trap and Qq-TOF. J Proteomics. 2010;73(6):1254\u201369.","journal-title":"J Proteomics"},{"key":"9288_CR44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ab.2007.07.029","volume":"370","author":"M Tucholska","year":"2007","unstructured":"Tucholska M, et al. Endogenous peptides from biophysical and biochemical fractionation of serum analyzed by matrix-assisted laser desorption\/ionization and electrospray ionization hybrid quadrupole time-of-flight. Anal Biochem. 2007;370:228\u201345.","journal-title":"Anal Biochem"},{"key":"9288_CR45","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00216-009-3345-0","volume":"396","author":"D Williams","year":"2010","unstructured":"Williams D, et al. Precipitation and selective extraction of human serum endogenous peptides with analysis by quadrupole time-of-flight mass spectrometry reveals posttranslational modifications and low-abundance peptides. Anal Bioanal Chem. 2010;396:1223\u201347.","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"9288_CR46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mas.20291","volume":"30","author":"P Zhu","year":"2011","unstructured":"Zhu P, et al. Mass spectrometry of peptides and proteins from human blood. Mass Spectrom Rev. 2011;30(5):685\u2013732.","journal-title":"Mass Spectrom Rev"},{"issue":"1","key":"9288_CR47","first-page":"67","volume":"2","author":"PZ Declan Williams","year":"2007","unstructured":"Declan Williams PZ, Bowden P, Stacey C, McDonell M, Kowalski P, Kowalski JM, Evans K, Diamandis EP, Michael Siu KW, Marshall J. Comparison of methods to examine the endogenous peptides of fetal calf serum clinical proteomics. Clin Proteomics. 2007;2(1):67\u201389.","journal-title":"Clin Proteomics."},{"issue":"4","key":"9288_CR48","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/pmic.200300677","volume":"4","author":"O Chertov","year":"2004","unstructured":"Chertov O, et al. Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry. Proteomics. 2004;4(4):1195\u2013203.","journal-title":"Proteomics"},{"issue":"10","key":"9288_CR49","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1074\/mcp.M300031-MCP200","volume":"2","author":"RS Tirumalai","year":"2003","unstructured":"Tirumalai RS, et al. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics. 2003;2(10):1096\u2013103.","journal-title":"Mol Cell Proteomics"},{"issue":"7","key":"9288_CR50","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/pmic.200300449","volume":"3","author":"R Pieper","year":"2003","unstructured":"Pieper R, et al. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics. 2003;3(7):1345\u201364.","journal-title":"Proteomics"},{"issue":"3","key":"9288_CR51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nbt0303-221","volume":"21","author":"SD Patterson","year":"2003","unstructured":"Patterson SD. Data analysis-the Achilles heel of proteomics. Nat Biotechnol. 2003;21(3):221\u20132.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"9288_CR52","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/bioinformatics\/bth092","volume":"20","author":"R Craig","year":"2004","unstructured":"Craig R, Beavis RC. TANDEM: matching proteins with tandem mass spectra. Bioinformatics. 2004;20(9):1466\u20137.","journal-title":"Bioinformatics"},{"issue":"11","key":"9288_CR53","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/1044-0305(94)80016-2","volume":"5","author":"JK Eng","year":"1994","unstructured":"Eng JK, McCormack AL, Yates JR. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom. 1994;5(11):976\u201389.","journal-title":"J Am Soc Mass Spectrom"},{"key":"9288_CR54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ab.2018.08.025","volume":"560","author":"J Dufresne","year":"2018","unstructured":"Dufresne J, et al. Re-evaluation of the rabbit myosin protein standard used to create the empirical statistical model for decoy library searching. Anal Biochem. 2018;560:39\u201349.","journal-title":"Anal Biochem"},{"issue":"2","key":"9288_CR55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ab.2010.10.027","volume":"409","author":"P Zhu","year":"2011","unstructured":"Zhu P, et al. Chi square comparison of tryptic peptide-to-protein distributions of tandem mass spectrometry from blood with those of random expectation. Anal Biochem. 2011;409(2):189\u201394.","journal-title":"Anal Biochem"},{"key":"9288_CR56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ab.2010.12.003","volume":"411","author":"P Zhu","year":"2011","unstructured":"Zhu P, et al. Peptide-to-protein distribution versus a competition for significance to estimate error rate in blood protein identification. Anal Biochem. 2011;411:241\u201353.","journal-title":"Anal Biochem"},{"issue":"1","key":"9288_CR57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling false discovery rate: a practical approach to multiple testing. J R Stat Soc. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc."},{"key":"9288_CR58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12014-018-9215-z","volume":"15","author":"J Dufresne","year":"2018","unstructured":"Dufresne J, et al. The plasma peptides of ovarian cancer. Clin Proteomics. 2018;15:41.","journal-title":"Clin Proteomics"},{"key":"9288_CR59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12014-018-9211-3","volume":"15","author":"J Dufresne","year":"2018","unstructured":"Dufresne J, et al. The plasma peptidome. Clin. Proteomics. 2018;15:39.","journal-title":"Proteomics"},{"issue":"4","key":"9288_CR60","first-page":"429","volume":"16","author":"OV Krokhin","year":"2005","unstructured":"Krokhin OV, Ens W, Standing KG. MALDI QqTOF MS combined with off-line HPLC for characterization of protein primary structure and post-translational modifications. J Biomol Tech. 2005;16(4):429\u201340.","journal-title":"J Biomol Tech"},{"issue":"6","key":"9288_CR61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1044-0305(02)00384-7","volume":"13","author":"JC Schwartz","year":"2002","unstructured":"Schwartz JC, Senko MW, Syka JE. A two-dimensional quadrupole ion trap mass spectrometer. J Am Soc Mass Spectrom. 2002;13(6):659\u201369.","journal-title":"J Am Soc Mass Spectrom"},{"issue":"8","key":"9288_CR62","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1021\/ac00104a020","volume":"67","author":"JR Yates 3rd","year":"1995","unstructured":"Yates JR 3rd, et al. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem. 1995;67(8):1426\u201336.","journal-title":"Anal Chem"},{"key":"9288_CR63","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jprot.2010.02.007","volume":"73","author":"P Bowden","year":"2010","unstructured":"Bowden P, et al. Meta sequence analysis of human blood peptides and their parent proteins. J Proteomics. 2010;73:1163\u201375.","journal-title":"J Proteomics"},{"issue":"7","key":"9288_CR64","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nbt.3267","volume":"33","author":"JM Chick","year":"2015","unstructured":"Chick JM, et al. A mass-tolerant database search identifies a large proportion of unassigned spectra in shotgun proteomics as modified peptides. Nat Biotechnol. 2015;33(7):743\u20139.","journal-title":"Nat Biotechnol"},{"key":"9288_CR65","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12014-017-9174-9","volume":"14","author":"J Dufresne","year":"2017","unstructured":"Dufresne J, et al. The proteins cleaved by endogenous tryptic proteases in normal EDTA plasma by C18 collection of peptides for liquid chromatography micro electrospray ionization and tandem mass spectrometry. Clin Proteomics. 2017;14:39.","journal-title":"Clin Proteomics"},{"key":"9288_CR66","doi-asserted-by":"crossref","unstructured":"Thavarajah T. et al. Re-evaluation of the 18 non-human protein standards used to create the Empirical Statistical Model for Decoy Library Searching. Anal Biochem. 2020:113680.","DOI":"10.1016\/j.ab.2020.113680"},{"key":"9288_CR67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ab.2016.07.021","volume":"513","author":"JC Howard","year":"2016","unstructured":"Howard JC, et al. OxLDL receptor chromatography from live human U937 cells identifies SYK(L) that regulates phagocytosis of oxLDL. Anal Biochem. 2016;513:7\u201320.","journal-title":"Anal Biochem"},{"issue":"4","key":"9288_CR68","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijid.2003.10.005","volume":"8","author":"G Ruiz Martin","year":"2004","unstructured":"Ruiz Martin G, et al. Plasma fibronectin as a marker of sepsis. Int J Infect Dis. 2004;8(4):236\u201343.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"9288_CR69","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1067\/mlc.2000.104462","volume":"135","author":"M Balduyck","year":"2000","unstructured":"Balduyck M, et al. Inflammation-induced systemic proteolysis of inter-alpha-inhibitor in plasma from patients with sepsis. J Lab Clin Med. 2000;135(2):188\u201398.","journal-title":"J Lab Clin Med"},{"issue":"6","key":"9288_CR70","doi-asserted-by":"crossref","first-page":"e0157024","DOI":"10.1371\/journal.pone.0157024","volume":"11","author":"JC Whitin","year":"2016","unstructured":"Whitin JC, et al. A novel truncated form of serum amyloid A in Kawasaki disease. PLoS ONE. 2016;11(6):e0157024.","journal-title":"PLoS ONE"},{"issue":"1","key":"9288_CR71","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","volume":"157","author":"J Kyte","year":"1982","unstructured":"Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982;157(1):105\u201332.","journal-title":"J Mol Biol"},{"issue":"10","key":"9288_CR72","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/jmr.2220","volume":"25","author":"M Spodzieja","year":"2012","unstructured":"Spodzieja M, et al. Interaction of serum amyloid A with human cystatin C-identification of binding sites. J Mol Recognit. 2012;25(10):513\u201324.","journal-title":"J Mol Recognit"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-020-09288-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-020-09288-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-020-09288-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T21:36:50Z","timestamp":1723153010000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-020-09288-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9288"],"URL":"https:\/\/doi.org\/10.1186\/s12014-020-09288-5","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"assertion":[{"value":"17 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human EDTA plasma samples were obtained under Ryerson Ethical Reviews Board Protocol REB 2015-207.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No original figures or tables from any other publisher was reproduced in this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}